Funding underway for groundbreaking cancer research
PRINCE GEORGE – The BC Cancer Foundation has launched a $2.2 million fundraising campaign to support a new, cutting-edge international precision radiation clinical trial, which will be led by Dr. Rob Olson and his team at BC Cancer Agency – Prince George Centre for the North. The new clinical trial, called SIMPLIFY, will be available at all six BC Cancer centres and at least 15 international sites.
The trial will help shape the future of precision radiation therapy internationally and further demonstrate BC Cancer’s global leadership in cancer research and innovation. SIMPLIFY will test the use of a single dose of Stereotactic ablative radiotherapy, a high-precision therapy that safely delivers higher doses of radiation to the tumour site, while limiting doses to healthy tissues, and is expected to reduce side effects and increase the chance of a complete remission for people with metastatic cancer.